시장보고서
상품코드
1309862

면역조직화학 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2018-2028년)

Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Product, By Application, By End User, By Region and By Competition

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 113 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 면역조직화학 시장은 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다. 이는 전 세계적으로 기술적으로 진보된 면역조직화학 솔루션의 도입과 함께 면역조직화학의 자동화 및 기계학습 도입에 대한 수요가 증가하고 있기 때문입니다. 또한, 제품 승인 증가와 질병 진단을 위한 기술적으로 진보된 IHC 시스템의 출시는 예측 기간 동안 시장 성장을 더욱 촉진하고 있습니다. 마찬가지로, 제약 및 생명공학 산업의 R&D 비용 증가는 시장 성장을 촉진하는 주요 요인입니다. 또한, 맞춤형 의료에 대한 선호도 증가, 암 유전체 연구 및 환자 참여 요구 사항의 증가는 예측 기간 동안 시장 수요를 촉진할 것으로 예상됩니다. 마찬가지로 병리학, 신경 병리학 및 혈액 병리학에서 항체 사용의 증가는 예측 기간 동안 면역조직화학 시장의 수요를 더욱 증가시킬 것으로 예상되며, 2021년 8월 FDA는 항 PD-1 면역 요법의 대상이 되는 dMMR 고형 종양 환자를 식별하기 위해 Roche의 VENTANA MMR RxDx Panel을 승인했습니다.

만성질환의 유병률 증가

노령 인구의 증가와 함께 암 유병률 증가는 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 예상되는 주요 요인 중 하나입니다. 2020년 7월에 발표된 공동 조사 위원회 보고서에 따르면 2020년 유럽연합에서 약 270만 명(비흑색종 암 제외)의 신규 암 환자가 진단될 것으로 예상되며, 유방암이 가장 많으며 2020년에는 약 35만 5,000명의 신규 환자가 발생할 것으로 추정됩니다. 또한, 만성 신장 질환의 유병률 증가는 예측 기간 동안 유리한 성장을 가져올 것으로 예상됩니다. 또한, 효소, 종양 특이적 항원, 종양 억제 유전자, 암 유전자 및 종양 세포 성장 마커를 식별하여 종양 분석에 대한 수요가 증가함에 따라 예측 기간 동안 면역조직화학 시장의 수요가 증가할 것으로 예상됩니다. 또한, 심혈관 질환, 심장병, 천식, 만성폐쇄성폐질환의 발병률 증가와 병원 방문 환자 수의 증가는 예측 기간 동안 면역조직화학 시장의 수요를 증가시킬 수 있습니다.

개별화 의료에 대한 수요 증가

비소세포폐암 환자를 위한 맞춤형 의료에 대한 수요가 증가함에 따라 예측 기간 동안 면역조직화학에 대한 수요가 증가했습니다. 또한, 이 기술은 가능한 한 완전하고 정확한 종양 조직학적 서브타이핑을 통해 적절한 치료 결정을 내리는 데 도움이 될 수 있습니다. 마찬가지로 BRAF V600E 및 IDH1 R132H와 같은 돌연변이 단백질을 검출할 수 있는 면역조직화학 분석의 가용성이 증가함에 따라 예측 기간 동안 시장을 더욱 견인할 것으로 보입니다. 면역조직화학 검사는 분자생물학적 검사의 대체 또는 보조 수단으로 유용합니다. 이러한 기술은 재현성이 높고, 기술적 복잡성이나 해석의 복잡성 없이도 저렴하게 이용할 수 있습니다. 2020년 7월 Laboratory Investigation 저널에 게재된 연구에 따르면, 다중 면역조직화학 분석 및 돌연변이 특이적 면역조직화학 분석의 시장 개척은 중요한 기술 혁신으로 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 예상됩니다. COVID-19 감염 검출을 위해 면역조직화학(IHC) 분석과 in situ hybridization(ISH) 분석이 사용되었습니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 고유한 요구에 따라 맞춤화할 수 있는 서비스를 제공합니다. 보고서는 다음과 같은 커스터마이징이 가능합니다.

회사 소개

  • 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

  • 시장의 정의
  • 시장 범위
    • 대상 시장
    • 조사 대상 연도
    • 주요 시장 세분화

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 면역조직화학 세계 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 지역별
    • 기업별
  • 시장 맵
    • 제품별
    • 용도별
    • 최종사용자별
    • 지역별

제6장 북미의 면역조직화학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 면역조직화학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 면역조직화학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 면역조직화학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 면역조직화학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 최종사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근의 전개
  • 인수합병
  • 제품 발표

제13장 면역조직화학 세계 시장 SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 상황

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
  • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • F.Hoffmann-La Roche Ltd.
    • Merck KGaA.
    • Danaher Corporation.
    • Perkinelmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology Inc.
    • Bio SB.
    • Agilent Technologies, Inc.
    • Abcam Plc.

제16장 전략적 제안

ksm 23.08.21

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in immunohistochemistry, along with the introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, the growing usage of antibodies in pathology, neuropathology, and hematopathology is expected to further enhance the demand for the immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche's VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.

Growing Prevalence of Chronic Diseases

The growing prevalence of cancer, along with the increasing geriatric population, is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission's report European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, the growing prevalence of chronic kidney disorders is expected to create lucrative growth during the forecast period. Furthermore, growing demand for analyzing tumors by identification of enzymes, tumor-specific antigens, tumor suppressor genes, oncogenes, and tumor cell proliferation markers is expected to enhance demand for the immunohistochemistry market during the forecast period. Moreover, the growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases, along with the rising number of patient visits to hospitals, can enhance the demand for the immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decisions by performing the most complete and accurate histological subtyping of tumors possible, which can enhance the demand for the market over the years. Similarly, the growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible, entail reasonable technical and interpretation complexity, and are also available at lesser costs. The growing development of multiplex and mutation-specific immunohistochemistry assays represents important innovations that are expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting COVID-19 infection.

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end-user, and by region. Based on the product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end-user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Developments

  • In June 2022, Roche launched HPV self-sampling solution and expanded cervical cancer screening options.
  • In February 2022, Moderna and Thermo Fisher Scientific announced a long-term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.
  • In February 2022, a new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis, which is called capillary electrophoresis, and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.

Market Players

Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Report Scope

In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Immunohistochemistry Market, By Product:

  • Antibodies
  • Equipment
  • Reagents
  • Kits

Immunohistochemistry Market, By Application:

  • Diagnostics
  • Drug Testing
  • Forensic applications

Immunohistochemistry Market, By End User:

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

Immunohistochemistry Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunohistochemistry Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Application
    • 5.3.3 By End User
    • 5.3.4 By Region

6. North America Immunohistochemistry Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Immunohistochemistry Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Immunohistochemistry Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Immunohistochemistry Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Immunohistochemistry Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Immunohistochemistry Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Immunohistochemistry Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Immunohistochemistry Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Immunohistochemistry Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Immunohistochemistry Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Immunohistochemistry Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Immunohistochemistry Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Immunohistochemistry Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Immunohistochemistry Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Immunohistochemistry Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Immunohistochemistry Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Immunohistochemistry Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Immunohistochemistry Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Immunohistochemistry Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Immunohistochemistry Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Immunohistochemistry Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
    • 10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
    • 10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Immunohistochemistry Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Immunohistochemistry Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Immunohistochemistry Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific Inc.
    • 15.6.2 F.Hoffmann-La Roche Ltd.
    • 15.6.3 Merck KGaA.
    • 15.6.4 Danaher Corporation.
    • 15.6.5 Perkinelmer, Inc.
    • 15.6.6 Bio-Rad Laboratories, Inc.
    • 15.6.7 Cell Signaling Technology Inc.
    • 15.6.8 Bio SB.
    • 15.6.9 Agilent Technologies, Inc.
    • 15.6.10 Abcam Plc.

16. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제